C

Celldex Therapeutics
D

CLDX

21.240
USD
0.89
(4.37%)
مغلق
حجم التداول
118,283
الربح لكل سهم
-3
العائد الربحي
-
P/E
-8
حجم السوق
1,410,213,679
أصول ذات صلة
A
ARVN
-0.18500
(-2.45%)
7.38000 USD
C
CRVS
-0.05000
(-1.18%)
4.18000 USD
F
FATE
-0.12000
(-8.63%)
1.27000 USD
MRNA
MRNA
-0.670
(-2.45%)
26.680 USD
N
NKTR
-0.21000
(-2.40%)
8.54000 USD
T
TGTX
-1.370
(-3.67%)
36.000 USD
المزيد
الأخبار المقالات

العنوان: Celldex Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.